Keywords: biotime, hextend, subject, fda, action, letter, food

BioTime's Hextend Subject Of FDA Action Letter

Article | 23 November 1998

Print This

The US Food and Drug Administration has completed its review ofBioTime's Hextend within 33 weeks of the New Drug Application submission, ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in